<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14(1)</volume><submitter>Ganjeh MS</submitter><pubmed_abstract>α-Glucosidase inhibitors have emerged as crucial agents in the management of type 2 diabetes mellitus. In the present study, a new series of coumarin-linked 2-phenylbenzimidazole derivatives 5a-m was designed, synthesized, and evaluated as anti-α-glucosidase agents. Among these derivatives, compound 5k (IC&lt;sub>50&lt;/sub> = 10.8 µM) exhibited a significant inhibitory activity in comparison to the positive control acarbose (IC&lt;sub>50&lt;/sub> = 750.0 µM). Through kinetic analysis, it was revealed that compound 5k exhibited a competitive inhibition pattern against α-glucosidase. To gain insights into the interactions between the title compounds and α-glucosidase molecular docking was employed. The obtained results highlighted crucial interactions that contribute to the inhibitory activities of the compounds against α-glucosidase. These derivatives show immense potential as promising starting points for developing novel α-glucosidase inhibitors.</pubmed_abstract><journal>Scientific reports</journal><pagination>7408</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10978946</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Coumarin linked to 2-phenylbenzimidazole derivatives as potent α-glucosidase inhibitors.</pubmed_title><pmcid>PMC10978946</pmcid><pubmed_authors>Mazlomifar A</pubmed_authors><pubmed_authors>Ganjeh MS</pubmed_authors><pubmed_authors>Shahvelayti AS</pubmed_authors><pubmed_authors>Moghaddam SK</pubmed_authors></additional><is_claimable>false</is_claimable><name>Coumarin linked to 2-phenylbenzimidazole derivatives as potent α-glucosidase inhibitors.</name><description>α-Glucosidase inhibitors have emerged as crucial agents in the management of type 2 diabetes mellitus. In the present study, a new series of coumarin-linked 2-phenylbenzimidazole derivatives 5a-m was designed, synthesized, and evaluated as anti-α-glucosidase agents. Among these derivatives, compound 5k (IC&lt;sub>50&lt;/sub> = 10.8 µM) exhibited a significant inhibitory activity in comparison to the positive control acarbose (IC&lt;sub>50&lt;/sub> = 750.0 µM). Through kinetic analysis, it was revealed that compound 5k exhibited a competitive inhibition pattern against α-glucosidase. To gain insights into the interactions between the title compounds and α-glucosidase molecular docking was employed. The obtained results highlighted crucial interactions that contribute to the inhibitory activities of the compounds against α-glucosidase. These derivatives show immense potential as promising starting points for developing novel α-glucosidase inhibitors.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2025-04-26T11:24:59.365Z</modification><creation>2025-04-06T13:42:16.173Z</creation></dates><accession>S-EPMC10978946</accession><cross_references><pubmed>38548784</pubmed><doi>10.1038/s41598-024-57673-z</doi></cross_references></HashMap>